Knight Therapeutics Inc. (TSX:GUD)
Canada flag Canada · Delayed Price · Currency is CAD
12.06
+0.01 (0.08%)
Nov 13, 2026, 4:00 PM EST

Knight Therapeutics Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Knight Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $13.10. The average 1-year stock price forecast is 8.62% higher than the current stock price, while the lowest is $12.75 (+5.72%) and the highest is $14.00 (+16.09%).

Price Target: $13.10 (+8.62%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$12.75$13.10$13.00$14.00
Change+5.72%+8.62%+7.79%+16.09%

Analyst Ratings

The average analyst rating for Knight Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26May '26Aug '26Sep '26Oct '26Nov '26
Strong Buy244444
Buy333333
Hold100000
Sell000000
Strong Sell000000
Total677777

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$12.25 → $12.75
BuyMaintains$12.25 → $12.75+5.72%Nov 6, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$11.00 → $12.75
BuyMaintains$11.00 → $12.75+5.72%Nov 6, 2026
RBC Capital
RBC Capital
Buy
Maintains
$11.00 → $13.00
BuyMaintains$11.00 → $13.00+7.79%Nov 6, 2026
Bloom Burton
Bloom Burton
Buy
Maintains
$12.00
BuyMaintains$12.00-0.50%Aug 7, 2026

Financial Forecast

Revenue This Year
565.20M
from 450.09M
Increased by 25.58%
Revenue Next Year
574.06M
from 565.20M
Increased by 1.57%
EPS This Year
0.14
from 0.02
Increased by 500.86%
EPS Next Year
0.26
from 0.14
Increased by 85.71%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
243.48M293.56M328.20M371.30M450.09M565.20M
Revenue Growth
22.03%20.57%11.80%13.13%21.22%25.58%
Gross Profit
115.41M138.06M152.65M174.41M200.23M270.84M
Gross Margin
47.40%47.03%46.51%46.97%44.49%47.92%
Operating Income
-12.83M-17.06M6.37M7.40M-2.35M91.17M
Net Income
15.68M-29.89M-16.84M4.33M-5.37M12.86M
EPS
----0.020.14
EPS Growth
-----48.11%500.86%
Forward PE
82.4395.3779.24157.06201.6786.14
Free Cash Flow
----67.05M45.30M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.

Revenue Forecast

Revenue202620272028
High570.8M
Avg565.2M
Low560.3M

Revenue Growth

Revenue Growth202620272028
High
26.8%
Avg
25.6%
Low
24.5%

EPS Forecast

EPS202620272028
High0.14
Avg0.14
Low0.14

EPS Growth

EPS Growth202620272028
High
500.9%
Avg
500.9%
Low
500.9%